We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Silk MicroRockets Provide Safe Drug Delivery

By HospiMedica International staff writers
Posted on 13 Jul 2016
Microscopic swimming devices made of biodegradable silk have the potential to be used in the human body for drug delivery and location of cancer cells, claims a new study.

Developed by researchers at the University of Sheffield (United Kingdom), the silk microrockets are just 300 microns in length and 100 microns in diameter, the thickness of a single human hair, and create their own thrust by using an entrapped enzyme as a catalyst, allowing them to swim through biologic fluids. More...
According to the researchers, the use of a biodegradable silk fibroin (SF) rocket and enzymatic fuel removes a major barrier to micro-rockets becoming a reality outside of the laboratory.

The silk microrockets are made using a three-dimensional (3D) reactive inkjet printing method that involves a liquid solution of dissolved SF mixed with an enzyme. The solution is then placed into a 3D inkjet printer, which builds up layers of ink to create the rocket. Printing methanol on the printed construct then triggers a reaction that forms a rigid shape, trapping the enzyme within a silk lattice structure. The enzyme acts as a catalyst, reacting with fuel molecules to produce bubbles that propel the rocket forward. The study describing the silk microrockets was published on June 27, 2016, in SMALL.

“By using a natural enzyme like catalase and silk which are fully biodegradable, our devices are far more biocompatible than earlier swimming devices,” said lead author Xiubo Zhao, PhD, of the department of chemical and biological engineering. “The inkjet printing technique also allows us to digitally define the shape of a rocket before it’s produced. This makes it a lot easier to optimize the shape in order to control the way the device swims.”

Reactive inkjet printing allows two different ink solutions to react together to generate a new compound or alternatively, as used by the researchers, to produce a change in polymorphic form of silk. Reactive inkjet printing also shares the advantages of conventional inkjet printing, allowing straightforward manufacture of 3D objects with well-controlled shape and size, for example, by utilizing a layer-by-layer approach.

Related Links:
University of Sheffield



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Hypodermic Syringe
SurTract™ Safety Syringe
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: A UTSW clinical trial studied a treatment strategy for kidney cancer with inferior vena cava tumor thrombus (IVC-TT) that used targeted radiation on the tumor thrombus followed by surgery to remove the kidney. (Photo courtesy of UT Southwestern)

Targeted Radiotherapy Before Surgery Improves Control of Kidney Cancer Thrombus

Inferior vena cava tumor thrombus occurs when kidney cancer extends into the body’s largest vein, potentially obstructing blood flow, progressing toward the heart, and making surgery more complex.... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Brain PET imaging could help identify Alzheimer’s patients most likely to benefit from available therapies (Image Credit: iStock)

Amyloid and Tau PET Guide Selection and Monitoring of Alzheimer’s Therapy

Alzheimer’s disease is the most common form of dementia and can be difficult to distinguish from other causes of cognitive decline. According to the World Health Organization (WHO), 57 million people were... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.